Inventor · disambiguated record
Willard Foss
Also filed as: FOSS WILLARD · FOSS WILLARD R
8 granted patents·8 pending applications·81 citations·filing 2012–2022
87Inventor score
Top patents by PatentIndex Score
16 records- 0196US11320416B1Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drugABRAXIS BIOSCIENCE LLC·Filed 2020·Granted May 3, 2022·4 cites·43 claims
- 0295US12061183B2Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drugABRAXIS BIOSCIENCE LLC·Filed 2022·Granted Aug 13, 2024·2 cites·18 claims
- 0395US10705070B1Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drugABRAXIS BIOSCIENCE LLC·Filed 2019·Granted Jul 7, 2020·8 cites·33 claims
- 0495US10527604B1Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxelABRAXIS BIOSCIENCE LLC·Filed 2016·Granted Jan 7, 2020·10 cites·32 claims
- 0595US10076501B2Use of polymeric excipients for lyophilization or freezing of particlesABRAXIS BIOSCIENCE LLC·Filed 2017·Granted Sep 18, 2018·17 cites·46 claims
- 0695US9585960B2Use of polymeric excipients for lyophilization or freezing of particlesABRAXIS BIOSCIENCE LLC·Filed 2012·Granted Mar 7, 2017·25 cites·20 claims
- 0794US10555912B2Use of polymeric excipients for lyophilization or freezing of particlesABRAXIS BIOSCIENCE LLC·Filed 2018·Granted Feb 11, 2020·9 cites·46 claims
- 0892US10900951B1Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxelABRAXIS BIOSCIENCE LLC·Filed 2019·Granted Jan 26, 2021·6 cites·25 claims
- 0968US2015051157A1Romidepsin formulations and uses thereofCELGENE CORP·Filed 2014·Application pending·0 cites
- 1062US2020407681A1Methods of expanding t cellsCELGENE CORP·Filed 2020·Application pending·0 cites
- 1160US2013184225A1Romidepsin formulations and uses thereofHUANG LIANFENG·Filed 2013·Application pending·0 cites
- 1259US2016367625A1Romidepsin formulations and uses thereofCELGENE CORP·Filed 2016·Application pending·0 cites
- 1358US2016137980A1Methods of expanding t cellsANTHROGENESIS CORP·Filed 2014·Application pending·0 cites
- 1453US2020206212A1Compositions and methods of use of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamideCELGENE CORP·Filed 2019·Application pending·0 cites
- 1545US2019247357A1Nanoparticle formulations and methods of making and using thereofABRAXIS BIOSCIENCE LLC·Filed 2017·Application pending·0 cites
- 1638US2018289802A1Formulations comprising pd-1 binding proteins and methods of making thereofCELGENE CORP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Willard Foss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →